[ad_1]
Exelixis, Inc. (NASDAQ:Exel) Q2 2025 Earnings Convention Name July 28, 2025 5:00 PM ET
Firm Individuals
l – Company Participant
Amy C. Peterson – Govt VP of Product Growth & Medical Affairs and Chief Medical Officer
Christopher J. Senner – Govt VP & CFO
Dana T. Aftab – Govt VP of Discovery and Translational Analysis & Chief Scientific Officer
Michael M. Morrissey – CEO, President & Director
Patrick Joseph Haley – Govt Vice President of Commercia
Susan T. Hubbard – Govt Vice President of Public Affairs & Investor Relations
Convention Name Individuals
Akash Tewari – Jefferies LLC, Analysis Division
Andrew Scott Berens – Leerink Companions LLC, Analysis Division
Anish Nikhanj – RBC Capital Markets, Analysis Division
Ashwani Verma – UBS Funding Financial institution, Analysis Division
Astika Sarith Goonwardene – Tristics Securities, Inc., Analysis Division
David Neil Lebowitz – Citigroup Inc., Analysis Division
Derek Christian Archila – Wells Fargo Securities, LLC, Analysis Division
Jason Matthew Gerberry – BofA Securities, Analysis Division
Michael Werner Schmidt – Guggenheim Securities, LLC, Analysis Division
Peter Richard Lawson – Barclays Financial institution PLC, Analysis Division
Sean M. Laman – Morgan Stanley, Analysis Division
Silvan Can Tuerkcan – Residents JMP Securities, LLC, Analysis Division
Stephen Douglas Willey – Stifel, Nicolaus & Firm, Integrated, Analysis Division
Sudan Naveen Loganathan – Stephens Inc., Analysis Division
Tsan-Your Hsieh – William Blair & Firm LLC, Analysis Division
Yaron Benjamin Werber – TD Cowen, Analysis Division
Operator
Good day, girls and gents, and welcome to the Exelixis Second Quarter 2025 Monetary Outcomes Convention Name. My title is Towanda, and I will be your operator for right now. As a reminder, this name is being recorded for replay functions.
I’d now like to show the decision over to your host for right now, Ms. Susan Hubbard, Govt Vice President of Public Affairs and Investor Relations. Please proceed.
[ad_2]
Supply hyperlink